# AB Science: Masitinib and AB8939 – Two compounds with breakthrough mechanism of action

> AB Science is currently developing two main compounds, masitinib, a highly selective tyrosine kinase inhibitor and AB8939\.

Generated by Yoast SEO v28.5, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Articles of Incorporation](https://www.ab-science.com/investors/regulated-information/articles-of-incorporation/)
- [Statuts](https://www.ab-science.com/investors/regulated-information/articles-of-incorporation/)
- [Information document](https://www.ab-science.com/investors/regulated-information/information-document/)
- [Document d’information](https://www.ab-science.com/investors/regulated-information/information-document/)
- [Outstanding shares and voting rights](https://www.ab-science.com/investors/regulated-information/monthly-disclosure-of-total-outstanding-shares-and-voting-rights/)

## Posts
- [AB Science annonce le succès du règlement\-livraison des titres émis dans le cadre de son placement privé de 14,2 millions d’euros annoncé le 10 aout 2026](https://www.ab-science.com/ab-science-announces-the-successful-settlement-and-delivery-of-securities-issued-as-part-of-its-e14-2-million-private-placement-announced-on-august-10-2026/)
- [AB Science announces the successful settlement and delivery of securities issued as part of its €14\.2 million private placement announced on August 10, 2026](https://www.ab-science.com/ab-science-announces-the-successful-settlement-and-delivery-of-securities-issued-as-part-of-its-e14-2-million-private-placement-announced-on-august-10-2026/)
- [AB Science annonce le succès d’augmentations de capital d’un montant brut total de 14,2 millions d’euros](https://www.ab-science.com/ab-science-announces-the-successful-completion-of-capital-increases-of-a-total-gross-amount-of-eur-14-2-million/)
- [AB Science announces the successful completion of capital increases of a total gross amount of EUR 14\.2 million](https://www.ab-science.com/ab-science-announces-the-successful-completion-of-capital-increases-of-a-total-gross-amount-of-eur-14-2-million/)
- [AB Science announces a slight delay in the publication of its 2025 half\-year financial report](https://www.ab-science.com/ab-science-announces-a-slight-delay-in-the-publication-of-its-2025-half-year-financial-report/)

## Categories
- [2021](https://www.ab-science.com/category/news/2021/)
- [2019](https://www.ab-science.com/category/news/2019/)
- [2020](https://www.ab-science.com/category/news/2020/)
- [2024](https://www.ab-science.com/category/news/2024/)
- [2025](https://www.ab-science.com/category/news/2025/)

## Tags
- [2019](https://www.ab-science.com/tag/2019/)
- [Masitinib](https://www.ab-science.com/tag/masitinib/)
- [ALS](https://www.ab-science.com/tag/als/)
- [AB10015](https://www.ab-science.com/tag/ab10015-2/)
- [riluzole](https://www.ab-science.com/tag/riluzole-2/)

## Optional
- [Sitemap index](https://www.ab-science.com/sitemap_index.xml)